These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6053004)

  • 41. Potentiation of the antitumor effect of 5-fluorouracil by some nucleotides, and their possible role in the potentiation.
    Tezuka M; Tamemasa O
    Jpn J Exp Med; 1983 Jun; 53(3):155-63. PubMed ID: 6663806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of repeated injection of dextran or polyvinylpyrrolidone on serum complement in guinea pigs.
    RICE CE; BOULANGER P; ANNAU E
    Can J Public Health; 1954 Jun; 45(6):264-7. PubMed ID: 13172646
    [No Abstract]   [Full Text] [Related]  

  • 43. Purification of tumor-associated embryonic substance from mouse ascites tumor cells: its cross-reactivity with human CEA.
    Saito M; Tanino T; Egawa K
    Jpn J Exp Med; 1980 Jun; 50(3):197-204. PubMed ID: 7431677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potentiation of interferon action.
    Schwarz LA; Fleischmann WR
    Tex Rep Biol Med; 1981-1982; 41():298-306. PubMed ID: 6184817
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired induction of type II interferon in tumor-bearing mice.
    Matsubara S; Suzuki M; Ishida N
    Cancer Res; 1980 Mar; 40(3):873-6. PubMed ID: 6162555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ascites fluid from immunized mice as a source of plant virus antibodies.
    Reddecliff JM; Ludwig EH
    Appl Microbiol; 1966 Sep; 14(5):834-5. PubMed ID: 5970471
    [No Abstract]   [Full Text] [Related]  

  • 47. Naturally occurring soluble H-2 specificity in mouse tissues.
    Haughton G
    Immunology; 1965 Aug; 9(2):193-9. PubMed ID: 5838453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progressive growth of transplanted tumors is accompanied by increasing serum concentrations of murine gamma fetal antigen.
    Higgins PJ; Marucs S; Hawrylko E
    Oncodev Biol Med; 1981; 2(1-2):77-87. PubMed ID: 6795603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AN ANALYSIS OF THE REACTANTS IN THE ONCOLYTIC REACTION.
    HARTVEIT F
    J Pathol Bacteriol; 1965 Apr; 89():551-5. PubMed ID: 14320297
    [No Abstract]   [Full Text] [Related]  

  • 50. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma.
    Baral R; Chattopadhyay U
    Int Immunopharmacol; 2004 Mar; 4(3):355-66. PubMed ID: 15037213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apparent lack of immunogenicity of estrogen-induced testicular Leydig cell tumors in BALB/c mice.
    Huseby RA; Page RH
    Cancer Res; 1982 Nov; 42(11):4332-8. PubMed ID: 6751521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Oncolysis of malignant tumors by Clostridium strain M 55].
    Möse JR; Möse G; Propst A; Heppner F
    Med Klin; 1967 Feb; 62(5):189-93. PubMed ID: 5590189
    [No Abstract]   [Full Text] [Related]  

  • 53. [Potentiation of cytotoxic effects of 5-fluorouracil by inosiplex on cancer cells].
    Miyoshi T; Ogawa S; Nobuhara M; Namba M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):440-4. PubMed ID: 6200078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitumor activity of tumor necrosis factor-alpha conjugated with polyvinylpyrrolidone on solid tumors in mice.
    Kamada H; Tsutsumi Y; Yamamoto Y; Kihira T; Kaneda Y; Mu Y; Kodaira H; Tsunoda SI; Nakagawa S; Mayumi T
    Cancer Res; 2000 Nov; 60(22):6416-20. PubMed ID: 11103807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of transient swelling upon the composition of kidney tissue.
    Wiggins PM
    Biochim Biophys Acta; 1968 May; 158(2):281-2. PubMed ID: 5654596
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of polyethylene glycol 6000 on the generation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells cultured in the presence or absence of inactivated stimulator tumor cells.
    Przepiorka D; Mokyr MB; Dray S
    Cancer Res; 1980 Dec; 40(12):4565-70. PubMed ID: 7438090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. "In vitro" interrelations BCG--Ehrlich carcinoma cells.
    Piţur I; Ionescu MD; Ciufecu E; Krohmalnic G; Drăghici D
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):167-74. PubMed ID: 6756341
    [No Abstract]   [Full Text] [Related]  

  • 58. Mechanisms of immune lysis. I. Physiological distinction between target cell death mediated by cytotoxic T lymphocytes and antibody plus complement.
    Russell JH; Masakowski VR; Dobos CB
    J Immunol; 1980 Mar; 124(3):1100-5. PubMed ID: 6965686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of Ehrlich's ascitic tumour cells in preparing hyperimmune fluid against third component (C3) of human serum complement.
    Gupta AK; Rao KM; Manja KS
    Indian J Exp Biol; 1980 May; 18(5):532-3. PubMed ID: 6776040
    [No Abstract]   [Full Text] [Related]  

  • 60. Is cancer dangerous to the immune system?
    Fuchs EJ; Matzinger P
    Semin Immunol; 1996 Oct; 8(5):271-80. PubMed ID: 8956455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.